Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ilaria Ponziani has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Impact of screening programs on the prenatal diagnosis (detection rate) of trisomy 13 and 18 over a 30-year period

    by Michele Santoro, Ilaria Ponziani, Laura Perna, Alessio Coi, Maria Valentina Abate, Lucia Pasquini

    Objective: To evaluate the impact of screening policies in Tuscany on the detection of trisomy 13 and trisomy 18 (T13/T18) with respect to time of diagnosis. A secondary aim was to evaluate the prevalence of these aneuploidies and to report the associated malformations. Methods: Data were extracted from the population-based Registry of Congenital Anomalies of Tuscany. All confirmed cases of T13/T18 among live births, stillbirths, miscarriages and terminations of pregnancy were included over a 30-year period (1994–2023). The prevalence for both aneuploidies was calculated overall and by age group (<35 years old; ≥ 35 years old). For prenatally diagnosed cases, median gestational age at diagnosis was calculated. The frequencies of the most common associated abnormalities were also calculated. Results: About 529 fetuses were diagnosed with T13/T18, respectively 133 (25.1%) and 396 (74.9%). The prevalence among 10,000 births was 1.67 (95% CI 1.40–1.98) for T13 and 4.98 (95% CI 4.45–5.49) for T18. Prenatal detection rate for T13 increased from 88.2% (95% CI 72.5–96.7) to 100% (95% CI 88.1–100.0). For T18, it increased from 87.5% (95% CI 79.2–93.4) to 100% (95% CI 95.0–100.0). Median gestational age at discovery gradually decreased for both trisomies through the study period, from 17 to 12 weeks. The most common anomalies in T13 were nervous system anomalies (27.8%) and congenital heart defects (9.8%). T18-associated anomalies included congenital heart defects (11.9%) and nervous system anomalies (10.1%). Conclusion: The implementation of screening policies led to an improvement in the rate of detection of T13/18 and a decrease in the median gestational age at diagnosis.

  • Invasive prenatal diagnosis in the era of cell-free fetal DNA: experience at a single center

    by Ilaria Ponziani, Marta Pallottini, Giulia Masini, Chiara Franchi, Silvia Balli, Lucia Pasquini

    Article: Invasive prenatal diagnosis in the era of cell-free fetal DNA: experience at a single center - Minerva Obstetrics and Gynecology 2023 October;75(5):393-8 - Minerva Medica - Journals

  • Elevated nuchal translucency, is it time to discuss the cut off?

    by Lucia Pasquini, Ilaria Ponziani, Elisa Spataro, Giulia Masini, Eleonora Biancareddu, Adalgisa Cordisco, Felice Petraglia

    Objective: We aimed to evaluate pregnancy and postnatal outcomes of fetuses with NT between 95th and 99th percentile at first trimester and whether they could benefit from further investigations rather that routine scans.Methods: Multicenter retrospective observational study which involved all cases with NT between 95th and 99th percentile from January 2015 to December 2020. Unfavorable outcome was considered as: miscarriage or intrauterine fetal death (IUFD), chromosomal abnormality/genetic syndrome, major malformation or neurodevelopmental delay. Study population outcomes were compared with general population.Results: The rate of unfavorable outcome was 25.44% (167 out of 667). We reported: 6 (0.90%) second trimester miscarriage or IUFD, 90 (13.49%) chromosomal abnormalities/genetic syndromes, 57 (8.55%) major malformations, 13 (1.95%) cases of neurodevelopmental delay. The incidence of chromosomal abnormalities/genetic syndromes and major malformations were significantly higher (OR 6.99 (IC 95% 4.33–11.28), P < 0.001 and OR 17.77 (IC 95%7.22–43.75), P < 0.001 respectively) compared to the general population. The incidence of neurodevelopmental delay was not increased (OR of 0.64 CI 95% 0.33–1.24 P = 0.185).Conclusions: Fetuses with NT between 95th and 99th percentile have an increased risk of pregnancy and postnatal adverse outcomes. According to our data it is reasonable to consider a lower cut of NT (NT > 95th percentile) for offering further investigations such as detailed ultrasound scan, fetal echocardiography and counseling where the option of performing fetal karyotype and CGH array should be discussed.


  • Open Access

    Obstetric and Neonatal Outcomes in Mild Idiopathic Polyhydramnios

    by Lucia Pasquini, Ilaria Ponziani, Marta Pallottini, Giulia Masini, Viola Seravalli, Carlo Dani, Mariarosaria Di Tommaso

    Background: Idiopathic polyhydramnios is a controversial clinical condition, as data on perinatal outcomes are conflicting and vary depending on the severity of the condition. The aim of the present study was to compare obstetric and neonatal outcomes between pregnant women with mild idiopathic polyhydramnios and a control population. Methods: A retrospective cohort study was performed at a single university hospital comparing the obstetrics and neonatal outcomes of pregnancies with mild idiopathic polyhydramnios (n = 109) and control pregnancies (n = 2550). Results: Cesarean section (CS) was significantly increased in the group with polyhydramnios compared to controls (46% vs. 32%, respectively, p = 0.047) due to a higher rate of emergency CS in the polyhydramnios group (p = 0.041) because of abnormal cardiotocography (7.3% vs. 2.9%; p = 0.018) or labor dystocia (8.2% vs. 2.9%; p = 0.006). No statistically significant difference was found in the Apgar score, in the rate of neonatal hypoxia, or in the incidence of macrosomia between groups. In four cases, additional diagnoses of anomalies were made after birth, with a rate of 3.2%, which is comparable to the general population. Conclusion: Besides an increased risk of CS, patients with mild idiopathic polyhydramnios should be reassured regarding maternal and feto-neonatal outcomes. The management of pregnancies with stable mild idiopathic polyhydramnios should not differ from uncomplicated pregnancies, except for the need for increased labor surveillance.


  • Screening for Common Fetal Trisomies in Twin Pregnancies: First-Trimester Combined, Cell-Free DNA, or Both?

    by Lucia Pasquini, Ilaria Ponziani, Enrico Periti, Laura Marchi, Carlo Luchi, Veronica Accurti, Francesco D’aMbrosi, Nicola Persico

    Objective: To examine the distribution of risks for fetal trisomies after first-trimester combined screening in twins and to investigate different strategies for clinical implementation of cell-free DNA (cfDNA) testing. Methods: We retrospectively analyzed all twin pregnancies undergoing first-trimester combined screening over a 10 years’ period. The population was stratified according to various risk cut-offs, and we examined different screening strategies for implementation of cfDNA testing in terms of impact on invasive testing rate, cfDNA test failure rate, and economic costs. Results: We included 572 twin pregnancies: 480 (83.92%) dichorionic and 92 (16.08%) monochorionic. Performing a first-line combined screening and offering cfDNA testing to the group with a risk between 1 in 10 and 1 in 1,000, would lead to an invasive testing rate of 2.45%, and cfDNA testing would be performed in 22.20% of the population. This strategy would be cost-neutral compared to universal combined screening alone. Conclusions: First-trimester combined screening results can be used to stratify twin pregnancies into different risk categories and select those that could be offered cfDNA testing. A contingent screening strategy would substantially decrease the need for invasive testing in twins and it would be cost-neutral compared to combined testing alone.